Vertex Pharmaceuticals Inc (VRTX)

Overview News Price History Option Chain Financials Why VRTX Down? Discussions Forecast Stock Split

Vertex Pharmaceuticals Inc Stock (VRTX) Financials Data

*All numbers in millions

Period End Date	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Period Length	3 Months	3 Months	3 Months	3 Months	3 Months
Revenues	6.87% 2,690.60	2,517.70	2,483.50	2,493.20	2,374.80
Cost Of Revenue	6.90% 342.60	368.00	318.70	308.60	266.90
Gross Profit	9.22% 2,348.00	2,149.70	2,164.80	2,184.60	2,107.90
Operating Expenses	4.07% 1,208.50	1,161.20	1,126.70	1,158.20	1,328.90
Benefits Costs and Expenses	3.02% 1,411.50	1,370.10	1,304.30	1,331.70	1,483.30
Costs And Expenses	1.43% 1,551.10	1,529.20	1,445.40	1,466.80	1,595.80
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	15.28% 1,139.50	988.50	1,038.10	1,026.40	779.00
Net Interest Income/Expense	1.89% -10.40	-10.60	-10.90	-11.20	-11.40
Interest Income/Expense After Provision For Losses	1.89% -10.40	-10.60	-10.90	-11.20	-11.40
Income/Loss From Continuing Operations Before Tax	11.46% 1,279.10	1,147.60	1,179.20	1,161.50	891.50
Income Tax Expense/Benefit	0.39% 179.50	178.80	143.90	245.80	191.70
Income/Loss From Continuing Operations After Tax	13.50% 1,099.60	968.80	1,035.30	915.70	699.80
Net Income/Loss	13.50% 1,099.60	968.80	1,035.30	915.70	699.80
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	258.20	-	258.00	257.70	257.40
Diluted Average Shares	261.00K% 261.10	0.10	260.60	260.40	260.30
Basic Earnings Per Share	13.30% 4.26	3.76	4.01	3.55	2.72
Diluted Earnings Per Share	13.48% 4.21	3.71	3.97	3.52	2.69
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

REGN

$754.87

0.24%

ARGX

$614.59

1.22%

ALNY

$253.74

0.15%

BNTX

$120.72

1.84%

BGNE

$206.16

7.31%